{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:51:07Z","timestamp":1789757467122,"version":"4.0.1"},"reference-count":20,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>\n              Up to 30% of patients with metastatic castration-resistant prostate cancer (mCRPC) have DNA damage repair (DDR) gene alterations, mainly in\n              <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n              . PARP inhibitors (PARPi) are standard treatments for\n              <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n              -altered patients with mCRPC, and evidence for platinum agents is limited. This study assesses single-agent platinum therapy in patients with mCRPC with and without DDR alterations.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>\n              This multicenter, retrospective study included patients with mCRPC with known DDR status treated with platinum monotherapy. DDR-positive (DDR+) patients had deleterious germline or somatic alterations in DDR genes (\n              <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n              ,\n              <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n              ,\n              <jats:italic toggle=\"yes\">CDK12<\/jats:italic>\n              ,\n              <jats:italic toggle=\"yes\">ATM<\/jats:italic>\n              ,\n              <jats:italic toggle=\"yes\">CHEK2<\/jats:italic>\n              ,\n              <jats:italic toggle=\"yes\">PALB2<\/jats:italic>\n              , or\n              <jats:italic toggle=\"yes\">FANCA<\/jats:italic>\n              ), whereas DDR-negative (DDR\u2013) patients had no such alterations. Prostate-specific antigen (PSA) response, progression-free survival (PFS, PSA\/clinical\/radiographic), and overall survival (OS) were assessed in DDR+ and DDR\u2013 groups.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              Among 129 patients, 81 had DDR+ and 48 had DDR\u2013 cancers. A PSA decline of \u226550% was demonstrated in 48% in BRCA, 9% in DDR+ non-BRCA, and 13% in DDR\u2013 patients (\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              &lt; .0001). Objective responses occurred in 37.5% in BRCA, 11% in DDR+ non-BRCA, and 13% in DDR\u2013 patients (\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              = .017). No response was reported in DDR+ patients who had received previous PARPi (n = 16). The median PSA response was 5 months for BRCA, 2 months for DDR+ non-BRCA, and 1.7 months for DDR\u2013 patients, respectively (\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              = .015), whereas the median clinical\/radiographic PFS was 4.7 months, 2.8 months, and 2 months, respectively (\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              = .2). In PARPi-na\u00efve patients, the median OS was 13.7 months for BRCA, 8.7 months for DDR+ non-BRCA, and 6.1 months for DDR\u2013 patients (\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              = .013).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>\n              Single-agent platinum agents show significant anticancer activity in\n              <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n              -mutated patients with mCRPC without previous PARPi exposure. With their low cost and broad availability, platinum agents offer a practical alternative, particularly in regions where PARPi are inaccessible.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/po-25-00310","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T19:59:09Z","timestamp":1754596749000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7685-051X","authenticated-orcid":true,"given":"Mihaela","family":"Aldea","sequence":"first","affiliation":[{"name":"Department of Cancer Medicine, Gustave Roussy, Villejuif, France"},{"name":"Paris-Saclay University, Kremlin-Bicetre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5557-2928","authenticated-orcid":true,"given":"Emeline","family":"Orillard","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Hospital of Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9706-3945","authenticated-orcid":true,"given":"Alice","family":"Bernard-Tessier","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cerbone","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4107-5522","authenticated-orcid":true,"given":"Casilda","family":"Llacer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario Virgen de La Victoria, M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, IBIMA, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-8124","authenticated-orcid":true,"given":"Kira-Lee","family":"Koster","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Roubaud","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7520-2908","authenticated-orcid":true,"given":"Ugo","family":"De Giorgi","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per Lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7004-9895","authenticated-orcid":true,"given":"Florence","family":"Joly","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-7168","authenticated-orcid":true,"given":"Fran\u00e7ois","family":"Cherifi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Rochand","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, H\u00f4pital Europ\u00e9en Georges-Pompidou (HEGP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4783-4788","authenticated-orcid":true,"given":"Aurelius","family":"Omlin","sequence":"additional","affiliation":[{"name":"Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3259-2226","authenticated-orcid":true,"given":"Himisha","family":"Beltran","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7398-0685","authenticated-orcid":true,"given":"Rafael","family":"Morales-Barrera","sequence":"additional","affiliation":[{"name":"Vall d'Hebron University Hospital, Vall d'Hebron Institute Oncology, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1639-8661","authenticated-orcid":true,"given":"Mylene","family":"Annonay","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Bianchini","sequence":"additional","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-595X","authenticated-orcid":true,"given":"Johann","family":"de Bono","sequence":"additional","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3691-6454","authenticated-orcid":true,"given":"Elena","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario Virgen de La Victoria, M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, IBIMA, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-5071","authenticated-orcid":true,"given":"Giulia","family":"Baciarello","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5746-6555","authenticated-orcid":true,"given":"Silke","family":"Gillessen","sequence":"additional","affiliation":[{"name":"Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland"},{"name":"Faculty of Biosciences, Universit\u00e0 della Svizzera Italiana, Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Thiery-Vuillemin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Hospital of Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-9474","authenticated-orcid":true,"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Gustave Roussy, Villejuif, France"},{"name":"Centre Oscar Lambret, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00339"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.1882"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.01.011"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022485"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911440"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01035"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214676"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10760"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn694"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000084201"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30408-5"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr004"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.1228"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21692"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30808"},{"key":"e_1_3_6_17_2","article-title":"DNA-damaging therapies in patients with prostate cancer and pathogenic alterations in homologous recombination repair genes","author":"Graham LS","unstructured":"Graham LS, Henderson NC, Kellezi O, et al: DNA-damaging therapies in patients with prostate cancer and pathogenic alterations in homologous recombination repair genes. JCO Precis Oncol 10.1200\/PO.24.00014","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/17562872241229876"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.6_suppl.43"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00532-x"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-00310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T19:59:14Z","timestamp":1754596754000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-00310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1200\/PO-25-00310"],"URL":"https:\/\/doi.org\/10.1200\/po-25-00310","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"2025-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500310"}}